ESMO WORLD CONGRESS ON GASTROINTESTINAL CANCER

ESMO 20th World Congress on Gastrointestinal Cancer

 

20-23 June, 2018 Barcelona
Close
N. Poster
Poster title
Applicant name
Status
  6-P Personalization of treatment for patients with stomach cancer using molecular genetic markers Igor Bykov Received Received
  17-P Overall survival of patients with HCC treated with sorafenib versus patients treated with supportive therapy in evidence in Oncology Cabinet of Municipal Hospital of Pascani in session 2013-2018 Elena-Carmen Bosteanu Received Received
  36-P High proliferation is independently associated with disease progression in metastatic pancreatic adenocarcinoma Sally Temraz Received Received
  132-P Poly-Ligand Profiling differentiates pancreatic cancer patients according to treatment benefit from gemcitabineplacebo versus gemcitabineevofosfamide and identifies candidate targets Valeriy Domenyuk Received Received
  154-P Real life triplet FIr/FOx chemotherapy in first line metastatic pancreatic ductal adenocarcinoma: Recommended schedule for expected activity and safety and phase II study Gemma Bruera Received Received
  176-P Analysis of various clinical and pathological factors affecting survival in patients diagnosed with pancreatic adenocarcinoma: Single institute study Ahmed Nagy Received Received
  180-P Neo-adjuvant FOLFIRINOX in borderline-resectable/locally advanced pancreatic adenocarcinoma: An updated analysis Sally Temraz Received Received
  187-P Erythrocyte membrane fatty acids as the potential biomarkers for detection of early-stage and progression of colorectal cancer Margarita Kruchinina Received Received
  206-P Intensive first line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: Preliminary phase II data and individual limiting toxicity syndromes prediction by pharmacogenomic biomarkers Gemma Bruera Received Received
  221-P Regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer: The optimization of pharmacological costs Jacopo Giuliani Received Received
  293-P Comorbidities (CM) and potential impact in outcomes of advanced colorectal cancer patients (ACC) in Argentina: EVIREPRO real life program Andres Jorge Schmilovich Received Received
  311-P Comparison between the toxicity profile of fluorouracil versus capecitabine concomitant with radiotherapy in patients with non-metastatic rectal cancer Ahmed Nagy Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: 8:30-17:30 Fri 8:30-15:00
11:09
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

ESMO WORLD CONGRESS ON GASTROINTESTINAL CANCER

ESMO 20th World Congress on Gastrointestinal Cancer

 

20-23 June, 2018 Barcelona
HELP LINE
Manage Orders
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 20/06/2018 TO 20/06/2019
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.20wcgic.2018 
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 12/06/2018
Upload Poster
Upload Oral Presentation of Video
Check your Poster
Upload
Poster
Upload Oral
Presentation or Video
Check
your Poster




PosterSessionOnline
Logo Draft
 
Logo Cert